Kyowa Kirin Co., Ltd. (TYO:4151)
2,251.50
+87.50 (4.04%)
At close: Mar 6, 2026
Kyowa Kirin Employees
Kyowa Kirin had 5,669 employees as of December 31, 2024. The number of employees decreased by 305 or -5.11% compared to the previous year.
Employees
5,669
Change (1Y)
-305
Growth (1Y)
-5.11%
Revenue / Employee
87.64M JPY
Profits / Employee
11.83M JPY
Market Cap
1,178.63B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ono Pharmaceutical | 4,287 |
| Santen Pharmaceutical | 3,849 |
| Astellas Pharma | 13,643 |
| Daiichi Sankyo Company | 19,765 |
| Otsuka Holdings | 35,338 |
| Chugai Pharmaceutical | 7,872 |
| JCR Pharmaceuticals | 987 |
| Perseus Proteomics | 32 |
Kyowa Kirin News
- 3 days ago - Amgen (AMGN) and Kyowa Kirin Halt Clinical Trials for Rocatinlimab Over Safety Concerns - GuruFocus
- 3 days ago - Kyowa Kirin stops development of skin condition treatment - Reuters
- 4 weeks ago - Amgen (AMGN) Ends Collaboration with Kyowa Kirin on Roctinlimab - GuruFocus
- 4 weeks ago - Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends - Benzinga
- 4 weeks ago - Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends - Benzinga
- 5 weeks ago - Amgen Inc. (AMGN) Announces Termination of License and Collaboration Agreement with Kyowa Kirin - GuruFocus
- 5 weeks ago - Amgen, Kyowa Kirin End Collaboration On Atopic Dermatitis Drug Rocatinlimab - Nasdaq
- 5 weeks ago - Amgen (AMGN) Ends Collaboration with Kyowa Kirin on Rocatinlimab - GuruFocus